CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week

Guideline24 February 2021

JOURNAL:National Institue for Health and Care Excellence Article Link

Dapagliflozin for treating chronic heart failure with reduced ejection fraction

National Institue for Health and Care Excellence Keywords: HFrEF; guideline; NICE

Full Text PDF